Clinical trial
Prospective Evaluation of Photorefractive Intrastromal Crosslinking (PiXL) Without Epithelium Debridement (Epi-on) in High Oxygen for Progressive Keratoconus.
NCT04668924 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Photorefractive Intrastromal Crosslinking (PiXL) Without Epithelium Debridement (Epi-on) in High Oxygen for Progressive Keratoconus.
- Lead sponsor
- Umeå University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 20, 2019
- Completion date
- February 5, 2026
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corneal crosslinking, corneal densitometry, corneal disorder, eye diseases, keratoconus, scheimpflug photography